Safety of everolimus plus exemestane in patients with hormone-receptor–positive, HER2–negative locally advanced or metastatic breast cancer progressing on prior non-steroidal aromatase inhibitors: primary results of a phase IIIb, open-label, single-arm, expanded-access multicenter trial (BALLET)
Titel:
Safety of everolimus plus exemestane in patients with hormone-receptor–positive, HER2–negative locally advanced or metastatic breast cancer progressing on prior non-steroidal aromatase inhibitors: primary results of a phase IIIb, open-label, single-arm, expanded-access multicenter trial (BALLET)
Auteur:
Jerusalem, G. Mariani, G. Ciruelos, E.M. Martin, M. Tjan-Heijnen, V.C.G. Neven, P. Gavila, J.G. Michelotti, A. Montemurro, F. Generali, D. Simoncini, E. Lang, I. Mardiak, J. Naume, B. Camozzi, M. Lorizzo, K. Bianchetti, S. Conte, P.